Olumiant 4 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FVJTK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $78,753
Award facts
- Contract value 100% obligated
- $78,752.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $78,752.51 delivery order to AmerisourceBergen Drug Corp for the supply of Olumiant 4 mg tablets (30-count units) under a firm fixed-price contract. The award, issued on July 10, 2025, with an ultimate completion date of July 11, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its Corporate Office location. This order falls under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime contract vehicle valued through December 2026 that supplies pharmaceutical products and medical commodities to support military healthcare systems globally.
The delivery order for Olumiant, a pharmaceutical treatment used in rheumatoid arthritis management, demonstrates AmerisourceBergen Drug Corp's ongoing role as a critical pharmaceutical distributor for federal medical procurement. As a major healthcare solutions provider, the company serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its comprehensive IDC, which encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The non-set-aside status of this award reflects the company's demonstrated capability to meet federal procurement requirements through open competition.
Quick answers
Who was awarded contract SPE2DB25FVJTK?
SPE2DB25FVJTK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 10, 2025.
How much is contract SPE2DB25FVJTK worth?
The government has obligated $78,753 on SPE2DB25FVJTK.
Is contract SPE2DB25FVJTK an order under another contract?
Yes. SPE2DB25FVJTK is a delivery order under SPE2DB25D3017, an indefinite delivery contract.
Was contract SPE2DB25FVJTK competed?
The extent of competition for SPE2DB25FVJTK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award